HRMY News and Press, Harmony Biosciences Holdings Inc. From 12/07/23

HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 Clinically meaningful improvements demonstrated in excessive daytime sleepiness and fatigue PR Newswire PLYMOUTH...

HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING Qualitative interview study informs future clinical trial endpoints for evaluating ZYN002 PR Newswire PLYMOUTH MEETING,...

2023-11-16 12:25:19 ET Summary Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper than their peers in November. CURE: Why mos...

HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa. , Nov. 16, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedica...

HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500™ Ranking attributed to 7,204% growth from fiscal year 2019 to 2022 PR Newswire PLYMOUTH MEETING, Pa. , Nov. 15, 2023 /PRNewswire...

HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS PR Newswire PLYMOUTH MEETING, Pa. , Nov. 8, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to ...

2023-11-06 08:00:00 ET Summary The S&P 500 was up 5.9% for the week, and is just 5.0% below the 2023 high watermark. The best performer last week was Blockchain, as Bitcoin continues to gain upward momentum. After several weeks of narrowing market participation, it now loo...

2023-11-01 07:13:09 ET Harmony Biosciences Holdings, Inc. (HRMY) Q3 2023 Earnings Conference Call October 31, 2023 08:30 AM ET Company Participants Luis Sanay - Head, IR Jeffrey Dayno - President & CEO Jeffrey Dierks - Chief Commercial Officer Kumar Budur...

2023-10-31 18:00:23 ET Image source: The Motley Fool. Harmony Biosciences (NASDAQ: HRMY) Q3 2023 Earnings Call Oct 31, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: Harmony Biosciences (HRMY) Q3 2023 Earnings Call...

2023-10-31 07:34:36 ET More on Harmony Biosciences Harmony Stock Tanks On Study Miss For Narcolepsy Drug: Problems May Be Escalating Harmony Biosciences: A Balancing Act As Investors Lose Some Sleep Mizuho says market fears for Harmony's Wakix drug are "overblown" ...